Compared with normal lung tissue cells with low expression of EGFR, these new nanoparticles can specifically target lung cancer cells with high expression of EGFR, and can also realize active targeting to tumor cells through surface modified ligands Accurate drug delivery [12]. The gene discussed is EGFR; the disease is lung cancer.